This topic contains a solution. Click here to go to the answer

Author Question: A phenotype workup is performed on a patient suspected to have ALL. The results indicate that some ... (Read 15 times)

maegan_martin

  • Hero Member
  • *****
  • Posts: 532
A phenotype workup is performed on a patient suspected to have ALL. The results indicate that some of the leukemic cells express myeloid markers , whereas others express T-cell markers. What is the most likely reason for this occurrence?
 
  a. Two patient samples were mixed.
  b. The diagnosis is bilineage acute leukemia.
  c. There is a problem in the interpretation of the data.
  d. The diagnosis is unilineage acute leukemia.

Question 2

What cytochemical stains are negative in ALL but positive in AML?
 
  a. PAS and myeloperoxidase
  b. PAS and Sudan Black B
  c. Nonspecific esterase and myeloperoxidase
  d. Acid phosphates and PAS



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jesse.fleming

  • Sr. Member
  • ****
  • Posts: 301
Answer to Question 1

Correct Answer: D

Answer to Question 2

Correct Answer: C




maegan_martin

  • Member
  • Posts: 532
Reply 2 on: Jun 25, 2018
Gracias!


kjohnson

  • Member
  • Posts: 330
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library